NCT06702982

Brief Summary

This quasi-experimental study evaluated a tele-nursing educational program's impact on improving the quality of life and managing chemotherapy-related symptoms in 74 adult cancer patients at Mansoura University Hospital in Egypt. Delivered via Telegram, the program involved weekly educational sessions, aiming to enhance symptom management and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 20, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 25, 2024

Completed
Last Updated

November 25, 2024

Status Verified

November 1, 2024

Enrollment Period

4 months

First QC Date

November 20, 2024

Last Update Submit

November 22, 2024

Conditions

Keywords

chemotherpaytele-nursingquality of life

Outcome Measures

Primary Outcomes (1)

  • cancer-related and treatment-related symptoms

    The M.D. Anderson Symptom Inventory Arabic Version (MDASI-A), adapted from Nejmi et al. (2010), was utilized to assess the severity of cancer-related and treatment-related symptoms in a manner accessible to Arabic-speaking patients. Designed in straightforward Arabic, the tool evaluates both the intensity of 13 core symptoms commonly experienced by cancer patients and their interference with daily functioning. This makes the MDASI-A comprehensive while remaining brief enough to avoid imposing a burden on respondents. The MDASI-A employs a 0-2 numerical scale (Never = 0, Sometimes = 1, Always = 2), ensuring its usability even among less-educated individuals. It is also adaptable for telephone, computer, and other electronic methods of administration. Scores were converted to percentages to classify symptom intensity into three categories: low (\<50%), average (50% to \<75%), and high (≥75%) based on the method proposed by Daisuke and Makoto (2022).

    3 months

Secondary Outcomes (1)

  • Quality of life for Cancer Patients

    3 months

Study Arms (1)

Enrolled participants

EXPERIMENTAL

The intervention administered in this study was a tele-nursing educational program aimed at improving cancer patients' management of chemotherapy-related symptoms and enhancing their quality of life. The program was delivered via a Telegram group, which provided a platform for regular interaction between the patients and nursing staff. The educational content was designed to address common chemotherapy-related symptoms, such as nausea, fatigue, pain, and loss of appetite, and to provide guidance on managing these symptoms effectively.

Behavioral: tele-nursing educational program

Interventions

The intervention administered in this study was a tele-nursing educational program aimed at improving cancer patients' management of chemotherapy-related symptoms and enhancing their quality of life. The program was delivered via a Telegram group, which provided a platform for regular interaction between the patients and nursing staff. The educational content was designed to address common chemotherapy-related symptoms, such as nausea, fatigue, pain, and loss of appetite, and to provide guidance on managing these symptoms effectively.

Enrolled participants

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed with cancer and receiving treatment at an outpatient chemotherapy center
  • Age from 20 less than 60 years.
  • Accept to participate in the study.
  • Had smart phones linked with internet
  • Educated and able to use Zoom and Telegram applications

You may not qualify if:

  • Having active, serious physical disease
  • Patients with mental disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansura university

Al Mansurah, Dakhalia, 35516, Egypt

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Alaa El Din M Abd Elaleem, PhD

    Faculty of Nursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Psychiatric and mental health Nursing

Study Record Dates

First Submitted

November 20, 2024

First Posted

November 25, 2024

Study Start

January 1, 2024

Primary Completion

April 30, 2024

Study Completion

August 30, 2024

Last Updated

November 25, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations